Clinical Trial Update: Community-Acquired Pneumonia (CAP) Surveillance

View source ↗

Summary

Bayer-sponsored Community-acquired pneumonia (CAP) surveillance clinical trial has completed; no drug-specific data is included in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Bayer | Conditions: Pneumonia | Status: COMPLETED